Infant Bacterial Therapeutics AB
IBT-B.ST
#9237
Rank
HK$0.57 B
Marketcap
HK$42.69
Share price
-0.56%
Change (1 day)
-32.42%
Change (1 year)

EPS for Infant Bacterial Therapeutics AB (IBT-B.ST)

EPS in 2024 (TTM): -HK$7.38

According to Infant Bacterial Therapeutics AB's latest financial reports the company's current EPS (TTM) is -HK$7.33. In 2023 the company made an earnings per share (EPS) of -HK$7.66 a decrease over its 2022 EPS that were of -HK$4.35.

EPS history for Infant Bacterial Therapeutics AB from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$7.38-3.77%
2023-HK$7.6676.22%
2022-HK$4.3526.49%
2021-HK$3.44-43.37%
2020-HK$6.0777.11%
2019-HK$3.435.56%
2018-HK$3.25-43.39%
2017-HK$5.74-10.87%
2016-HK$6.44-30.65%
2015-HK$9.28359.45%
2014-HK$2.02